Related Experiment Video
Updated: Aug 7, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
14.9K
Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium
Guneswar Sethi1,2, Rinku Polachirakkal Varghese3, Avinash Kant Lakra4
1Department of Predictive Toxicology, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea.
Scientific Reports
|July 10, 2024
Summary
A novel multi-epitope vaccine targeting Mycobacterium tuberculosis (Mtb) was designed using immunoinformatics. This potential vaccine shows promise for inducing specific immune responses against tuberculosis, addressing limitations of current BCG vaccines.
Area of Science:
- Computational biology
- Vaccinology
- Immunology
Background:
- Tuberculosis (Mtb) remains a global health crisis with high mortality and increasing drug resistance.
- The current BCG vaccine offers limited protection against adult pulmonary tuberculosis and latent infection reactivation.
- There is a critical need for new, effective vaccines against Mtb.
Purpose of the Study:
- To design a novel multi-epitope vaccine against Mtb using an immunoinformatic approach.
- To evaluate the potential immunogenicity and efficacy of the designed vaccine through in silico methods.
Main Methods:
- An immunoinformatic strategy was employed to select epitopes from five Mtb antigenic proteins.
- Epitopes were combined with an adjuvant and analyzed for physicochemical properties.
- Molecular dynamics simulations, docking, MM-PBSA, immune simulations, and in silico cloning were utilized.
Main Results:
- The designed multi-epitope vaccine exhibited favorable antigenic, soluble, and non-allergic properties.
- Strong interactions were observed between the vaccine construct and Toll-like receptors (TLR2 and TLR3).
- In silico analyses predicted a strong immunogenic profile and potential for inducing specific immune responses.
Conclusions:
- The in silico-designed multi-epitope vaccine is a promising candidate for tuberculosis prevention.
- Further in vivo studies are essential to validate the vaccine's efficacy and immunogenicity.
- This approach offers a potential new strategy for developing advanced tuberculosis vaccines.
Keywords:
Mycobacterium tuberculosisDockingIn silico cloningMolecular dynamics simulationMulti-epitope vaccine
